The role of leukodepletion in the control of transfusion-transmitted disease (Q40507844)

21 September 2017

1 reference

title

The role of leukodepletion in the control of transfusion-transmitted disease (English)

1 reference

21 September 2017

Goldman M

1

1 reference

21 September 2017

Delage G

series ordinal

2

1 reference

21 September 2017

language of work or name

1 reference

1 January 1995

1 reference

Transfusion Medicine Reviews

21 September 2017

published in

1 reference

21 September 2017

volume

9

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

9-19

1 reference

Leukocyte Reduction in Blood Component Therapy

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Leukodepletion blood filters: filter design and mechanisms of leukocyte removal

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Prestorage leukocyte depletion of blood products in a closed system.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Low retention of white cell fragments by polyester fiber white cell-reduction platelet filters

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

White cell counting in red cells and platelets: how few can we count?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Quality control for deglycerolized red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Reducing the Risk for Transfusion-transmitted Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Prevention of transfusion-acquired cytomegalovirus infections in newborn infants

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

The risk of transmitting cytomegalovirus infection by fresh frozen plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Removal of cytomegalovirus DNA from donor blood by filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Cytomegalovirus Infection in Dialysis Patients and Personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Use of Deglycerolized Red Blood Cells to Prevent Posttransfusion Infection with Cytomegalovirus in Neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Posttransfusion cytomegalovirus infection in neonates: role of saline-washed red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Use of leucocyte-poor blood components to prevent primary cytomegalovirus (CMV) infection in patients with acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Prevention of transfusion‐transmitted cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Blood banking not what it used to be, experts say

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Human T-Cell Lymphotropic Virus Type I and II in Transfusion Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Five cases of Pseudomonas sepsis transmitted by blood transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Posttransfusion Serratia marcescens septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Strategies for the avoidance of bacterial contamination of blood components

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

The role of white cells in the transmission of Yersinia enterocolitica in blood components

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filters

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Prevention of growth of Yersinia enterocolitica in blood by polyester fiber filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Removal of Yersinia enterocolitica from AS-1 red cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Prevention of Yersinia enterocolitica growth in red-blood-cell concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Yersinia enterocolitica and white cell filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Clinical laboratory comparison of the 10-ml isolator blood culture system with BACTEC radiometric blood culture media.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Transfusion-transmitted Yersinia enterocolitica infection. Protection through buffy coat removal and failure of the bacteria to grow in platelet-rich or platelet-poor plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Yersinia enterocolitica

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Transfusion-associated Serratia marcescens infection: studies of the mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Bacteremia due to serratia marcescens

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Effect of prestorage white cell reduction on bacterial growth in platelet concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

White cells protect donor blood against bacterial contamination

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Do white cells in stored blood components reduce the likelihood of posttransfusion bacterial sepsis?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Yersinia enterocolitica and blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Removal of Yersinia enterocolitica from red-blood-cell concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

White cell reduction and bacterial proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

Complement-mediated bactericidal action and the removal of Yersinia enterocolitica by white cell filters

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980027-6

7 January 2021

10.1016/S0887-7963(05)80027-6

Identifiers

DOI

1 reference

21 September 2017

1 reference